Hui Ling
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 27
- MicroRNA in disease regulation 22
- Molecular Biology top 2%
- Circular RNAs in diseases 15
- RNA modifications and cancer 13
- Plant-derived Lignans Synthesis and Bioactivity 11
- Phytochemical compounds biological activities 6
- Pharmacology top 2%
- Oncology top 5%
- Immunology top 10%
-
- Garlic and Onion Studies 12
-
- Synthetic Organic Chemistry Methods 6
- Co-authors
- George A. CălinMuller FabbriMartin PichlerMasahisa OhtsukaShi‐Wu ChenIoana Berindan‐NeagoeRiccardo FoddeYaochun Zhang
- Journals
- Bioorganic & Medicinal Chemistry Letters (8 papers)International Journal of Molecular Sciences (5 papers)Oncotarget (5 papers)
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Hui Ling
121 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 2.6k
- Molecular Biology 3.4k
- Pharmacology 233
- Oncology 717
- Immunology 316
Countries citing papers authored by Hui Ling
This map shows the geographic impact of Hui Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Ling more than expected).
Fields of papers citing papers by Hui Ling
This network shows the impact of papers produced by Hui Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Ling. The network helps show where Hui Ling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 9 | |
| 7 | 2020 | 12 | |
| 8 | 2018 | 44 | |
| 9 | 2017 | 38 | |
| 10 | 2016 | 61 | |
| 11 | 2016 | 53 | |
| 12 | 2015 | 19 | |
| 13 | 2015 | 9 | |
| 14 | 2014 | 68 | |
| 15 | 2014 | 165 | |
| 16 | 2014 | 20 | |
| 17 | 2011 | 21 | |
| 18 | 2008 | 26 | |
| 19 | 2005 | 9 | |
| 20 | Inhibitory effect of diallyl disulfide on human gastric cancer cell line MGC803 in vitro | 2003 | 3 |
About Hui Ling
Hui Ling is a scholar working on Cancer Research, Molecular Biology, Pharmacology, Oncology and Genetics, having authored 125 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (27 papers), MicroRNA in disease regulation (22 papers), Circular RNAs in diseases (15 papers), RNA modifications and cancer (13 papers), Garlic and Onion Studies (12 papers), Plant-derived Lignans Synthesis and Bioactivity (11 papers), Synthetic Organic Chemistry Methods (6 papers) and Phytochemical compounds biological activities (6 papers). The work is most often cited by research in Cancer Research (2.6k citations), Molecular Biology (3.4k citations), Pharmacology (233 citations), Oncology (717 citations) and Immunology (316 citations). Hui Ling has collaborated with scholars based in China, United States and Austria. Frequent co-authors include George A. Călin, Muller Fabbri, Martin Pichler, Masahisa Ohtsuka, Shi‐Wu Chen, Ioana Berindan‐Neagoe, Riccardo Fodde, Yaochun Zhang, Frank J. Slack and Ken R. Vincent. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, International Journal of Molecular Sciences, Oncotarget, European Journal of Medicinal Chemistry and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.